Pharmacology of Cardiovascular Drugs

Critical Heart Disease in Infants and Children

Volumn , Issue , 2006, Pages 173-203

  Tabbutt, Sarah ^a,b   Helfaer, Mark A ^a,c   Nichols, David G ^d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Division of Pulmonary and Critical Care Medicine   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884853956     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301281-2.50009-6     Document Type: Chapter

References (254)

1. Abman SH, Chatfield BA, Hall SL, McMurtry IF Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990, 259:H1921-H1927.
2. Adatia I, Perry S, Landzberg M, et al. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995, 25:1656-1664.
3. Agnoletti G, Scotti C, Panzali AF, et al. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: Effect of cardiac surgery. Eur J Cardiothorac Surg 1993, 7:533-539.
4. Alousi AA, Farah AE, Lesher GY, Opalka CJ Cardiotonic activity of amrinone Win 40680 [5-amino-3,4'-bipyridine-6-(1H)-one]. Circ Res 1979, 45:666-677.
5. Anonymous Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10: Pediatric advanced life support. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000, 102:I291-I342.
6. Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW Afterload reduction and cardiac output in infants early after intracardiac surgery. Am J Cardiol 1977, 39:445-451.
7. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998, 116:973-980.
8. Ationu A, Singer DR, Smith A, et al. Studies of cardiopulmonary bypass in children: Implications for the regulation of brain natriuretic peptide. Cardiovasc Res 1993, 27:1538-1541.
9. Azeka E, Franchini Ramires JA, et al. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 2002, 40:2034-2038.
10. Bailey JM, Miller BE, Lu W, et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999, 90:1012-1018.
11. Banner W, Vernon DD, Minton SD, Dean JM Nonlinear dobutamine pharmacokinetics in a pediatric population. Crit Care Med 1991, 19:871-873.
12. Barrington K, Chan W The circulatory effects of epinephrine infusion in the anesthesized piglet. Pediatr Res 1993, 33:190-194.
13. Barst RJ Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatr Clin North Am 1999, 46:331-345.
14. Barst RJ Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999, 99:1197-1208.
15. Bartelds B, Gratama JW, Meuzelaar KJ, et al. Comparative effects of isoproterenol and dopamine on myocardial oxygen consumption, blood flow distribution and total body oxygen consumption in conscious lambs with and without an aortopulmonary left to right shunt. J Am Coll Cardiol 1998, 31:473-481.
16. Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. Chest 1996, 109:1302-1312.
17. Beekman RH, Rocchini AP, Dick M, et al. Vasodilator therapy in children: Acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation. Pediatrics 1984, 73:43-51.
18. Belgorosky A, Weller G, Chaler E, et al. Evaluation of serum total thyroxine and triiodothyronine and their serum fractions in nonthyroidal illness secondary to congenital heart disease. Studies before and after surgery. J Endocrinol Invest 1993, 16:499-503.
19. Bengur AR, Beekman RH, Rocchini AP, et al. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation 1991, 83:523-527.
20. Benitz WE, Malachowski N, Cohen RS, et al. Use of sodium nitroprusside in neonates: Efficacy and safety. J Pediatr 1985, 106:102-110.
21. Bennett NR, Abbott TR The use of sodium nitroprusside in children. Anaesthesia 1977, 32:456-463.
22. Bennett-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. JAMA 1996, 275:687-692.
23. Benson LN, Bohn D, Edmonds JF, et al. Nitroglycerin therapy in children with low cardiac index after heart surgery. Cardiovasc Med 1979, 4:207-215.
24. Benzing G, Helmsworth JA, Schreiber JT, Kaplan S Nitroprusside and epinephrine for treatment of low output in children after open-heart surgery. Ann Thorac Surg 1979, 27:523-528.
25. Benzing G, Helmsworth JA, Schrieber JT, et al. Nitroprusside after open-heart surgery. Circulation 1976, 54:467-471.
26. Berg RA, Donnerstein RL, Padbury JF Dobutamine infusions in stable, critically ill children: Pharmacokinetics and hemodynamic actions. Crit Care Med 1993, 21:678-686.
27. Berg RA, Padbury JF, Donnerstein RL, et al. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents. J Pharmacol Exp Ther 1993, 265:1232-1238.
28. Berk JL, Hagen JF, Koo R Effect of alpha and beta adrenergic blockade on epinephrine induced pulmonary insufficiency. Ann Surg 1976, 183:369-376.
29. Berlin CM The treatment of cyanide poisoning in children. Pediatrics 1970, 46:793-796.
30. Bersten AD, Rutten AJ, Summersides G, Ilsley AH Epinephrine infusion in sheep: Systemic and renal hemodynamic effects. Critical Care Med 1994, 22:994-1001.
31. Bettendorf M, Schmidt KG, Grulich-Henn J, et al. Tri-iodothyronine treatment in children after cardiac surgery: A double-blind, randomized, placebo-controlled study. Lancet 2000, 356:529-534.
32. Bettendorf M, Schmidt KG, Tiefenbacher U, et al. Transient secondary hypothyroidism in children after cardiac surgery. Pediatric Research 1997, 41:375-379.
33. Bigam DL, Barrington KJ, Jirsch DW, Cheung PY Effects of a continuous epinephrine infusion on regional blood flow in awake newborn piglets. Biology of the Neonate 1998, 73:198-206.
34. Bohn DJ, Poirier CS, Edmonds JF, Barker GA Hemodynamic effects of dobutamine after cardiopulmonary bypass. Crit Care Med 1980, 8:367-371.
35. Borow KM, Neumann A, Arensman FW, Yacoub MH Cardiac and peripheral vascular responses to adrenoceptor stimulation and blockade after cardiac transplantation. J Amer Coll Cardiol 1989, 14:1229-1238.
36. Bouissou F, Meguira B, Rostin M, et al. Long term therapy by captopril in children with renal hypertension. Clin Exp Hypertens 1986, 8A:841-845.
37. Bristow MR, Minobe W, Rasmussen R, et al. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 1988, 247:1039-1045.
38. Bristow MR Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol 1993, 71:12-22C.
39. Brodde OE, Broede A, Daul A, et al. Receptor systems in the non-failing human heart. Basic Res Cardiol 1992, 87:1-14.
40. 2-adrenoreceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 1989, 14:323-331.
41. Brogan TV, Bratton SL, Lynn AM Thyroid function in infants following cardiac surgery: Comparative effects of iodinated and noniodinated topical antiseptics. Critical Care Med 1997, 25:1583-1587.
42. Broner CW, Stidham GL, Westenkirchner DF, Watson DC A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children. J Pediatr 1990, 117:986-989.
43. Brown CG, Martin DR, Pepe PE, et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992, 327:1051-1055.
44. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience. J Pediatr 2001, 138:505-511.
45. Bush A, Busst C, Booth K, et al. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?. Circulation 1986, 74:135-144.
46. Bush A, Busst C, Knight WB, Shinebourne EA Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy. Am Rev Respir Dis 1987, 136:767-769.
47. Cardenas-Rivero N, Chernow B, Stoiko MA, et al. Hypocalcemia in critically ill children. J Pediatr 1989, 114:946-951.
48. Caspi J, Coles JG, Benson LN, et al. Age-related response to epinephrine-induced myocardial stress. A functional and ultrastructural study. Circulation 1991, 84:III394-III399.
49. Castillo L, de Rojas T, Chapman T, et al. Nitric oxide synthesis is decreased in persistent pulmonary hypertension of the newborn. Pediatr Res 1993, 33:20A.
50. Chang AC, Atz AM, Wernovsky G, et al. Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995, 23:1907-1914.
51. Chernow B, Holbrook P, D'Angona DS, et al. Epinephrine absorption after intratracheal administration. Anesth Analg 1984, 63:829-832.
52. Chernow B, Rainey TG, Lake CR Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982, 10:409-416.
53. Cheung PY, Barrington KJ, Pearson RJ, et al. Systemic, pulmonary and mesenteric perfusion and oxygenation effects of dopamine and epinephrine. Am J Resp & Critical Care Med 1997, 155:32-37.
54. Chiariello M, Gold HK, Leinbach RC, et al. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 1976, 54:766-773.
55. Chidsey CA, Braunwald E, Morrow AG Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 1965, 39:442-451.
56. Cotecchia S, Schwinn DA, Randall RR, et al. Molecular cloning and expression of the cDNA for the hamster α1- adrenergic receptor. Proc Natl Acad Sci USA 1988, 85:7159-7163.
57. Cottrell JE, Casthely P, Brodie JD, et al. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med 1978, 298:809-811.
58. Cuneo BF, Zales VR, Blahunka PC, Benson DW Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol 1994, 15:296-301.
59. Cutaia M, Porcelli RJ Pulmonary vascular reactivity after repetitive exposure to selected biogenic amines. J Appl Physiol 1983, 55:1868-1876.
60. Damen J, Hitchcock JF Reactive pulmonary hypertension after a switch operation. Successful treatment with glyceryl trinitrate. Br Heart J 1985, 53:223-225.
61. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998, 101:325-334.
62. Deal JE, Barratt TM, Dillon MJ Management of hypertensive emergencies. Arch Dis Child 1992, 67:1089-1092.
63. Dillon TR, Janos GG, Meyer RA, et al. Vasodilator therapy for congestive heart failure. J Pediatr 1980, 96:623-629.
64. Dixon RA, Kobilka BK, Strader DJ, et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 1986, 321:75-79.
65. Donahoo JS, Roland JM, Kan J, et al. Prostaglandin E1 as an adjunct to emergency cardiac operation in neonates. J Thorac Cardiovasc Surg 1981, 81:227-231.
66. Driscoll DJ, Gillette PC, Duff DF, et al. Hemodynamic effects of dobutamine in children. Am J Cardiol 1979, 43:581-585.
67. Driscoll DJ, Gillette PC, Ezrailson EG, Schwartz A Inotropic response of the neonatal canine myocardium to dopamine. Pediat Res 1978, 12:42-45.
68. Driscoll DJ, Gillette PC, Lewis RM, et al. Comparative hemodynamic effects of isoproterenol, dopamine, and dobutamine in the newborn dog. Pediat Res 1979, 13:1006-1009.
69. Dupuy PM, Shore SA, Drazen JM, et al. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992, 90:421-428.
70. Earl CQ, Linden J Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone. J Cardiovasc Pharmacol 1986, 8:864-872.
71. Eldadah MK, Schwartz PH, Harrison R, Newth CJ Pharmacokinetics of dopamine in infants and children. Crit Care Med 1991, 19:1008-1011.
72. Escrig A, Marin R, Mas M Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms. J Urology 1999, 162:2205-2210.
73. Feldman AM Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 1993, 87:IV27-IV34.
74. Fenek RO Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothor Vasc Anesth 1992, 6:554-562.
75. Fenek RO Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothor Vasc Anesth 1992, 6:563-567.
76. Feuerstein G, Yue TL, Ma X, Ruffolo RR Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 1998, 41:17-24.
77. Fisher DG, Schwartz PH, Davis AL Pharmacokinetics of exogenous epinephrine in critically ill children. Crit Care Med 1993, 21:111-117.
78. Fleischmann LE Management of hypertensive crisis in children. Pediatric Annals 1977, 6:410-414.
79. Francoe M, Troncy E, Blaise G Inhaled nitric oxide: Technical aspects of administration and monitoring. Crit Care Med 1998, 26:782-796.
80. Fratacci MD, Frostell CG, Chen TY, et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991, 75:990-999.
81. Freed MD, Heymann MA, Lewis AB, et al. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation 1981, 64:899-905.
82. Frielle T, Collins S, Daniel KW, et al. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci USA 1987, 84:7920-7924.
83. Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991, 83:2038-2047.
84. Gidding SS, Rocchini AP, Beekman R, et al. Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta. N Engl J Med 1985, 312:1224-1228.
85. Gilbert EM, Olsen SL, Renlund DG, Bristow MR Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 1993, 71:23C-29C.
86. The Pharmacological Basis of Therapeutics 1990, Pergamon Press, NY. A.G. Gilman, T.W. Rall, A.S. Nies (Eds.).
87. Girardin E, Berner M, Rouge JC, et al. Effect of low dose dopamine on hemodynamic and renal function in children. Pediatr Res 1989, 26:200-203.
88. Girardin EP, Berner ME, Favre HR, et al. Atrial natriuretic factor after heart operations in children. Relation to hemodynamic and renal parameters. J Thorac Cardiovasc Surg 1991, 102:526-531.
89. Goenen M, Pedemonte O, Baele P, Col J Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 1985, 56:33B-38B.
90. Goetting MG, Paradis NA High dose epinephrine in refractory pediatric cardiac arrest. Crit Care Med 1989, 17:1258-1262.
91. Goetting MG, Paradis NA High-dose epinephrine improves outcome from pediatric cardiac arrest. Ann Emerg Med 1991, 20:22-26.
92. Gold J, Cullinane S, Chen J, et al. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 2000, 85:506-508.
93. Goldman AP, Delius RE, Deanfield JE, et al. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension. Ann Thorac Surg 1996, 62:750-755.
94. Gomberg-Maitland M, Frishman WH Thyroid hormone and cardiovascular disease. Am Heart J 1998, 135:187-196.
95. Goodall M, Alton H Metabolism of 3-hydroxytyramine (dopamine) in human subjects. Biochem Pharmacol 1968, 17:905-914.
96. Gordillo-Paniagua G, Velasquez-Jones L, Martini R, Valdez-Bolanos E Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 1975, 87:799-802.
97. Gregory JS, Bonfiglio MF, Dasta JF, et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991, 19:1395-1400.
98. Guiha NH, Cohn JN, Mikulic E, et al. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 1974, 291:587-591.
99. Guller B, Fields AI, Coleman MG, Holbrook PR Changes in cardiac rhythm in children treated with dopamine. Crit Care Med 1978, 6:151-154.
100. Habib DM, Padbury JF, Anas NG, et al. Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 1992, 20:601-608.
101. Hamilton MA, Stevenson LW, Fonarow GC, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 1998, 81:443-447.
102. Hamilton MA, Stevenson LW, Luu M, Walden JA Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990, 16:91-95.
103. Harding SE, Brown LA, Wynne DG, et al. Mechanisms of beta-adrenoreceptor desensitization in the failing human heart. Cardiovasc Resear 1994, 28:1451-1460.
104. Hayes JS, Bowling N, Boder GB, Kauffman R Molecular basis for the cardiovascular activities of amrinone and AR-L57. J Pharmacol Exp Ther 1984, 230:124-132.
105. Ho ECK, Moss AJ The syndrome of mesenteric arteritis following surgical repair of aortic coarctation. Pediatrics 1972, 49:40-45.
106. Hoffman TM, Wernovsky G, Atz AM Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003, 107:996-1002.
107. Honerjager P, Schafer-Korting M, Reiter M Involvement of cyclic AMP in the direct inotropic action of amrinone, biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol 1981, 318:112-120.
108. Hyman AL, Lippton HL, Kadowitz PJ Autonomic regulation of the pulmonary circulation. J Cardiovasc Pharmacol 1985, 7:S80-S95.
109. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981, 218:739-749.
110. Ilbawi MN, Idriss FS, DeLeon SY, et al. Hemodynamic effects of intravenous nitroglycerin in pediatric patients after heart surgery. Circulation 1985, 72:II101-II107.
111. Journois D, Pouard P, Mauriat P, et al. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994, 107:1129-1135.
112. Kariya T, Wille LJ, Dage RC Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043. J Cardiovasc Pharmacol 1982, 4:509-514.
113. Katzenschlager R, Weiss K, Rogatti W, et al. Interaction between prostaglandin E1 and nitric oxide (NO). Thromb Res 1991, 62:299-304.
114. Kaumann AJ, Lobnig BM Mode of action of (-)-pinodolol on feline and human myocardium. Br J Pharmacol 1986, 89:207-218.
115. Kelly RA, Balligand JL, Smith TW Nitric oxide and cardiac function. Circ Res 1996, 79:363-380.
116. Kermode J, Butt W, Shann F Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery. Br Heart J 1991, 66:175-178.
117. Kikura M, Lee MK, Safon RA, et al. The effects of milrinone on platelets in patients undergoing cardiac surgery. Anesth Analges 1995, 81:44-48.
118. Kikura M, Levy JH, Michelsen LG, et al. The effects of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analges 1997, 85:16-22.
119. Kimball TR, Daniels SR, Meyer RA, et al. Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect. Am J Cardiol 1991, 68:1377-1382.
120. Kinsella JP, Abman SH Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics 1993, 91:997-998.
121. Klarr JM, Faix RG, Pryce CJ, Bhatt-Mehta V Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 1994, 125:117-122.
122. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995, 333:1522-1527.
123. Kobilka BK, Dixon RA, Frielle T, et al. cDNA for the human beta 2-adrenergic receptor: A protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987, 84:46-50.
124. Kobilka BK, Kobilka TS, Daniel K, et al. Chimeric alpha 2-, beta 2-adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science 1988, 240:1310-1316.
125. Kunathai S, Sholler GF, Celermajer JM, et al. Nitroprusside in children after cardiopulmonary bypass: A study of thiocyanate toxicity. Pediatr Cardiol 1989, 10:121-124.
126. Laguenie G, Berg A, Saint-Maurice JP, Dinh-Xuan AT Measurement of nitrogen dioxide formation from nitric oxide by chemiluminescence in ventilated children. Lancet 1993, 341:969.
127. Lambert DG Signal transduction: G proteins and second messengers. Br J Anaesth 1993, 71:86-95.
128. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95:1122-1125.
129. Landzberg JS, Parker JD, Gauthier DF, Colucci WS Effects of myocardial alpha 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation 1991, 84:1608-1614.
130. Lawless S, Burckart G, Diven W, et al. Amrinone in neonates and infants after cardiac surgery. Crit Care Med 1989, 17:751-754.
131. Le Tulzo Y, Seguin P, Gacouin A, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study. Intensive Care Med 1997, 23:664-670.
132. Leier CV, Heban PT, Huss P, et al. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978, 58:466-475.
133. Leier CV, Webel J, Bush CA The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 1977, 56:468-472.
134. LeJemtel TH, Keung E, Sonnenblick EH, et al. Amrinone: A new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 1979, 59:1098-1104.
135. Lewis AB, Freed MD, Heymann MA, et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 1981, 64:893-898.
136. Lewis AB, Takahashi M, Lurie PR Administration of prostaglandin E1 in neonates with critical congenital cardiac defects. J Pediatr 1978, 93:481-485.
137. Lock JE, Olley PM, Coceani F Enhanced beta-adrenergic-receptor responsiveness in hypoxic neonatal pulmonary circulation. Am J Physiol 1981, 240:H697-H703.
138. Lomasney JW, Lorenz W, Allen LF, et al. Expansion of the alpha 2-adrenergic receptor family: Cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci USA 1990, 87:5094-5098.
139. Lurie KG, Bristow MR, Reitz BA Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg 1983, 86:195-201.
140. Lynch SK, Lemley KV, Polak MJ The effect of dopamine on glomerular filtration rate in normotensive, oliguric premature neonates. Pediatr Nephrol 2003, 18:649-652.
141. Maguire JF, Geha RS, Umetsu DT Myocardial specific creatine phosphokinase isoenzyme elevation in children with asthma treated with intravenous isoproterenol. J Allergy Clin Immunol 1986, 78:631-636.
142. Malay MB, Ashton RC, Landry DW, Townsend RN Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999, 47:699-704.
143. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest 1993, 103:1826-1831.
144. McGowan FX, Davis PJ, Siewers RD, del Nido PJ Coronary vasoconstriction mediated by enothelin-1 in neonates. Reversal by nitroglycerin. J Thorac Cardiovasc Surg 1995, 109:88-97.
145. McLaughlin VV, Genthner DE, Panella MM, Rich S Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998, 338:273-277.
146. Meadow WL, Rudinsky BF, Strates E Selective elevation of systemic blood pressure by epinephrine during sepsis-induced pulmonary hypertension in piglets. Pediatr Res 1986, 20:872-875.
147. Merrin RG Autonomic nervous system pharmacology. Anesthesia 1990, Churchill Livingstone, NY. R.D. Miller (Ed.).
148. Miall-Allen VM, De Vries LS, Whitelaw AGL Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 1987, 62:1068-1069.
149. Miall-Allen VM, Whitelaw AG Response to dopamine and dobutamine in the preterm infant less than 30 weeks gestation. Crit Care Med 1989, 17:1166-1169.
150. Michael JR, Guerci AD, Koehler RC, et al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984, 69:822-835.
151. Mikhail MS, Hunsinger SY, Goodwin SR, Loughlin GM Myocardial ischemia complicating therapy of status asthmaticus. Clin Pediatr 1987, 26:419-421.
152. Million D, Zillner P, Baumann R Oxygen pressure-dependent control of carbonic anhydrase synthesis in chick embryonic erythrocytes. Am J Physiol 1991, 261:R1188-R1196.
153. Mitani Y, Okuda YR, Shimpo H, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997, 96:454-461.
154. Molenaar P, Smolich JJ, Russell FD, et al. Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J Pharmocol Exp Ther 1990, 255:393-400.
155. Moncada S, Palmer RM, Higgs EA Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharm Rev 1991, 43:109-142.
156. Morales DL, Gregg D, Helman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thor Surg 2000, 69:102-106.
157. Moran JL, O'Fathartaigh MS, Peisach AR, et al. Epinephrine as an inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993, 21:70-77.
158. Morris K, Beghetti M, Petros A, et al. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 2000, 28:2974-2978.
159. Motomura S, Reinhard-Zerkowski H, Daul A, Brodde OE On the physiologic role of beta-2 adrenoreceptors in the human heart: In vitro and in vivo studies. Am Heart J 1990, 119:608-619.
160. Muntz KH, Zhao M, Miller JC Downregulation of myocardial beta-adrenergic receptors. Receptor subtype selectivity. Circ Res 1994, 74:369-375.
161. Nakamura KT, Matherne GP, Jose PA, et al. Effects of epinephrine on the renal vascular bed of fetal, newborn, and adult sheep. Pediatr Res 1988, 23:181-186.
162. Nakano H, Ueda K, Saito A Acute hemodynamic effects of nitroprusside in children with isolated mitral regurgitation. Am J Cardiol 1985, 56:351-355.
163. Neirotti RA, Alvarez CE, Campos MD, et al. Total anomalous pulmonary venous connection. Scand J Thorac Cardiovasc Surg 1991, 25:97-100.
164. NIOSH recommendation for occupational safety and health standards 1998. MMWR 1988, 37:1-29.
165. Nishioka K, Nakanishi T, George BL, Jarmakani JM The effect of calcium on the inotropy of catecholamine and paired electrical stimulation in the newborn and adult myocardium. J Mol Cell Cardiol 1981, 13:511-520.
166. Notterman DA, Greenwald BM, Moran F, et al. Dopamine clearance in critically ill infants and children: Effect of age and organ system dysfunction. Clin Pharmacol Ther 1990, 48:138-147.
167. Nussbaum J, Zane EA, Thys DM Esmolol for the treatment of hypercyanotic spells in infants with tetralogy of Fallot. J Cardiothorac Anesth 1989, 3:200-202.
168. Odeh M Tumor necrosis factor-alpha as a myocardial depressant substance. Int J Cardiol 1993, 42:231-238.
169. Opie LH, Kaplan N, Poole-Wilson PA Angiotension-converting enzyme inhibitors and conventional vasodilators. Drugs for the Heart 1995, WB Saunders, Philadelphia. 4th ed. L.H. Opie (Ed.).
170. Oshita S, Uchimoto R, Oka H, et al. Correlation between arterial blood pressure and oxygenation in tetralogy of Fallot. J Cardiothorac Anesth 1989, 3:597-600.
171. Ostman-Smith I, Wettrell G, Riesenfeld T A cohort study of childhood hypertrophic cardiomyopathy. J Am Coll Cardiol 1999, 34:1813-1822.
172. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349-1355.
173. Palmer RF, Lasseter KC Sodium nitroprusside. N Engl J Med 1975, 292:294-296.
174. Perkin RM, Levin DL, Webb R, et al. Dobutamine: A hemodynamic evaluation in children with shock. J Pediatr 1982, 100:977-983.
175. Perondi MB, Reis AG, Paiva EF, et al. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med 2004, 350:1722-1730.
176. Phoon CK, Wu ST, Parmley WW Digoxin's minimal inotropic effect is not limited by sodium-calcium exchange in the intact immature rabbit heart. J Cardiovasc Pharmacol Ther 1997, 2:97-105.
177. Pfaffinger PJ, Martin JM, Hunter DD, et al. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature 1985, 317:536-538.
178. Podbregar M, Voga G, Horvat M, et al. Bolus versus continuous low dose of enalaprilat in congestive heart failure with acute refractory decompensation. Cardiology 1999, 91:41-49.
179. Porcelli RJ, Cutaia MV Pulmonary vascular reactivity to bio-genic amines during acute hypoxia. Am J Physiol 1988, 255:H329-H334.
180. Prins I, Plotz FB, Uiterwaal CS, van Vught HJ Low-dose dopamine in neonatal and pediatric intensive care: A systemic review. Intensive Care Med 2001, 27:206-210.
181. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF) Intravenous niseritide vs. nitroglycerin in the treatment of the decompensated congestive heart failure: A randomized controlled trial. JAMA 2002, 287:1531-1540.
182. Ramamoorthy C, Anderson GD, Williams GD, Lynn AM Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 1998, 86:283-289.
183. Reddy VM, Liddicoat JR, McElhinney DB, et al. Hemodynamic effects of epinephrine, bicarbonate and calcium in the early postnatal period in a lamb model of single-ventricle physiology created in utero. J Am Coll Cardiol 1996, 28:1877-1883.
184. Regan JW, Kobilka TS, Yang-Feng TL, et al. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci USA 1988, 85:6301-6305.
185. Reves JG, Karp RB, Buttner EE, et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982, 66:49-55.
186. Reyes G, Schwartz PH, Newth CJ, Eldadah MK The pharmacokinetics of isoproterenol in critically ill pediatric patients. J Clin Pharmacol 1993, 33:29-34.
187. Rich MW, McSherry F, Williford WO, Yusuf S Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: The DIG study. J Am Coll Cardiol 2001, 38:806-813.
188. Roberts JD, Fineman JR, Morin FC, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997, 336:605-610.
189. Roberts JD, Lang P, Bigatello LM Inhaled nitric oxide in congenital heart disease. Circulation 1993, 87:447-453.
190. Robinson BW, Gelband H, Mas MS Selective pulmonary and systemic vasodilator effects of amrinone in children: New therapeutic implications. J Am Coll Cardiol 1993, 21:1461-1465.
191. Robishaw JD, Foster KA Role of G proteins in the regulation of the cardiovascular system. Annu Rev Physiol 1989, 51:229-244.
192. Rosenzweig SB, Starc TJ, Chen JM Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999, 100:182-186.
193. Ross MP, Allen-Webb EM, Pappas JB, McGough EC Amrinone-associated thrombocytopenia: Pharmacokinetic analysis. Clin Pharmacol Ther 1993, 53:661-667.
194. Rouby JJ, Gory G, Bourrelli B, et al. Resistance to sodium nitroprusside in hypertensive patients. Crit Care Med 1982, 10:301-304.
195. Royster RL, Butterworth JF, Prielipp RC, et al. A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass. Anesth Analg 1992, 74:3-13.
196. Roze JC, Tohier C, Maingueneau C, et al. Response to dobutamine and
197. Rubin LJ Primary pulmonary hypertension. N Engl J Med 1997, 336:111-117.
198. Rudinsky BF, Komar KJ, Strates E, Meadow WL Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets. Crit Care Med 1987, 15:1127-1130.
199. Ruffolo RR, Spradlin TA, Pollock GD, et al. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 1981, 219:447-455.
200. Ruffolo RR Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system. Pharmacol Biochem Behav 1985, 22:827-833.
201. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21:1296-1303.
202. Russell IA, Zwass MS, Fineman JR, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998, 87:46-51.
203. Sato Y, Matsuzawa H, Eguchi S Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery. Jpn Circ J 1982, 46:1059-1072.
204. Scammell AM, Arnold R, Wilkinson JL Captopril in treatment of infant heart failure: A preliminary report. Int J Cardiol 1987, 16:295-301.
205. Schleien CL, Dean JM, Koehler RC, et al. Effect of epinephrine on cerebral and myocardial perfusion in an infant animal preparation of cardiopulmonary resuscitation. Circulation 1986, 73:809-817.
206. Schranz D, Droege A, Broede A, et al. Uncoupling of human cardiac beta-adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest. Circulation 1993, 87:422-426.
207. Schranz D, Zepp F, Iversen S, et al. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Crit Care Med 1992, 20:1243-1249.
208. Schulze-Neick I, Bultmann M, Werner H, et al. Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease in newborns and children. Am J Cardiol 1997, 80:360-363.
209. Schwartz PH, Eldadah MK, Newth CJ The pharmacokinetics of dobutamine in pediatric intensive care unit patients. Drug Metab Dispos Biol Fate Chem 1991, 19:614-619.
210. Schwinn DA, Lomasney JW, Lorenz W, et al. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem 1990, 265:8183-8189.
211. Schwinn DA Adrenoceptors as models for G protein-coupled receptors: Structure, function and regulation. Br J Anaesth 1993, 71:77-85.
212. Sealey WC Paradoxical hypertension after repair of coarctation of the aorta: A review of its causes. Ann Thorac Surg 1990, 50:323-329.
213. Seri I Cardiovascular, renal, and endocrine actions of dopamine in neonates and children. J Pediatr 1995, 126:333-344.
214. Shaddy RE, Curtin EL, Sower B, et al. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: Rationale and design. Am Heart J 2002, 144:383-389.
215. Shaddy RE, Teitel DF, Brett C Short-term hemodynamic effects of captopril in infants with congestive heart failure. Am J Dis Child 1988, 142:100-105.
216. Shaddy RE, Viney J, Judd VE, McGough EC Continuous intravenous phenylephrine infusion for treatment of hypoxemic spells in tetralogy of Fallot. J Pediatr 1989, 114:468-470.
217. Shaw NJ, Wilson N, Dickinson DF Captopril in heart failure secondary to a left to right shunt. Arch Dis Child 1988, 63:360-363.
218. Shryock JC, Belardinelli L Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology and pharmacology. Am J Cardiol 1997, 79:2-10.
219. Silver MA, Horton DP, Ghali JK, Elkayam U Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 2002, 39:798-803.
220. Silverman HJ, Penaranda R, Orens JB, Lee NH Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993, 21:31-39.
221. Siwy BK, Sadove AM Acute management of dopamine infiltration injury with Regitine. Plast Reconstr Surg 1987, 80:610-612.
222. Smerling A, Gersony WM Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 1990, 18:1288-1290.
223. Steen PA, Tinker JH, Pluth JR, et al. Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary bypass in man. Circulation 1977, 57:378-384.
224. Stiell IG, Hebert PC, Weitzman BN, et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992, 327:1045-1050.
225. Stueven HA, Thompson B, Aprahamian C, et al. Lack of effectiveness of calcium chloride in refractory asystole. Ann Emerg Med 1985, 14:630-632.
226. Stueven HA, Thompson B, Aprahamian C, et al. The effectiveness of calcium chloride in refractory electromechanical dissociation. Ann Emerg Med 1985, 14:626-629.
227. Subhedar NV, Shaw NJ Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Libr 2000, 1:1-19.
228. Suzuki A, Yamagishi M, Kimura K, et al. Functional behavior and morphology of the coronary artery wall in pateints with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996, 27:291-296.
229. Takeuchi K, del Nido PJ, Ibrahim AE, et al. Vesnarinone and amrinone reduce the systemic inflammatory response syndrome. J Thorac Cardiovasc Surg 1999, 117:375-382.
230. The Neonatal Inhaled Nitric Oxide Study Group Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997, 336:597-604.
231. Thomas JA, Marks BH Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978, 41:233-243.
232. Tinker JH, Michenfelder JD Sodium nitroprusside: Pharmacology, toxicology and therapeutics. Anesthesiology 1976, 45:340-354.
233. Turanlahti MI, Laitinen PO, Sarna SJ, Pesonen E Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Heart 1998, 79:169-174.
234. Vane JR, Botting RM Pharmacodynamic profile of prostacyclin. Am J Cardiol 1995, 75:3A-10A.
235. Vincent RN, Click LA, Williams HM, et al. Esmolol as an adjunct in the treatment of systemic hypertension after operative repair of coarctation of the aorta. Am J Cardiol 1990, 65:941-943.
236. Ward A, Brogden RN, Heel RC, et al. Amrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs 1983, 26:468-502.
237. Ward KE, Pryor RW, Matson JR, et al. Delayed detection of coarctation in infancy: Implications for timing of newborn follow-up. Pediatrics 1990, 86:972-976.
238. Weesner KM Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension. Cathet Cardiovasc Diagn 1991, 24:10-15.
239. Wei EP, Moskowitz MA, Boccalini P, Kontos HA Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992, 70:1313-1319.
240. Wessel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993, 88:2128-2138.
241. Wessel DL, Adatia I, Thompson JE, Hickey PR Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994, 22:930-938.
242. Wessel DL Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass. Crit Care Med 1993, 21:S344-S345.
243. Wessel DL, Adatia I, Van Marter LJ, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997, 100:E7.
244. Wessel DL, Triedman JK, Wernovsky G, et al. Pulmonary and systemic hemodynamics of amrinone in neonates following cardiopulmonary bypass. Circulation 1989, 80:II488.
245. Wiest DB, Garner SS, Uber WE, Sade RM Esmolol for management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 1998, 115:890-897.
246. Wiest DB, Trippel DL, Gillette PC, Garner SS Pharmacokinetics of esmolol in children. Clin Pharmacol Ther 1991, 49:618-623.
247. Williams DB, Kiernan PD, Schaff HV, et al. The hemodynamic response to dopamine and nitroprusside following right atrium-pulmonary artery bypass (Fontan procedure). Ann Thorac Surg 1982, 34:51-57.
248. Wong AF, McCulloch LM, Sola A Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. J Pediatr 1992, 121:980-983.
249. Yaster M, Simmons RS, Tolo VT, et al. A comparison of nitroglycerin and nitroprusside for inducing hypotension in children: A double-blind study. Anesthesiology 1986, 65:175-179.
250. Yusuf S, Theodoropoulos S, Mathias CJ, et al. Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 1987, 75:696-704.
251. Zaritsky A, Lotze A, Stull R, Goldstein DS Steady-state dopamine clearance in critically ill infants and children. Crit Care Med 1988, 16:217-220.
252. Zayek M, Wild L, Roberts JD, Morin FC Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension. J Pediatr 1993, 123:947-952.
253. Zhang J, Penny DJ, Kim NS, et al. Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999, 81:F99-F104.
254. Zhao M, Muntz KH Differential downregulation of beta-2 adrenergic receptors in tissue compartments of rat heart is not altered by sympathetic denervation. Circ Res 1993, 73:393-400.